Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Signals Willingness To Grant Regulatory Flexibility For Cell and Gene Therapy Products In CMC Reviews

Jun 12 2019

• By Joanne S. Eglovitch

3d illustration of T cells or cancer cells

Related Content

Regenerative Medicine Therapies: Manufacturing Changes May Not Impact RMAT Designation

Feb 19 2019

Cell Therapies: US FDA Asked To Clarify Development Standards For Early-Phase Trials

May 22 2019

CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

Jun 22 2018

Shutdown Bite Tightens At US FDA, But Gene Therapy To Get 50 More Reviewers

Jan 16 2019

Woodcock, Califf Give Thumbs Up To Certain 21<sup>st</sup> Century Cures Provisions

Dec 15 2016

Additional Topics

United States Manufacturing Quality BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window